Skip to main content
Premium Trial:

Request an Annual Quote

Co-Diagnostics Awarded $2.3M from Bill and Melinda Gates Foundation for TB, HPV Tests

NEW YORK – Co-Diagnostics announced on Tuesday that it has been awarded two grants from the Bill and Melinda Gates Foundation totaling $2.3 million for its tuberculosis and human papillomavirus tests. 

The $1.3 million grant for tuberculosis and $987,000 grant for HPV will be applied toward completing the tests for the Co-Dx PCR Home platform, which are intended for priority global markets, Co-Diagnostics said in a statement.

Last week, the Salt Lake City-based firm announced it had received $1.2 million from the US National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Tech program to finish development of an upper respiratory panel for the Co-Dx PCR Home platform.

"We believe that our new platform has the potential to dramatically improve access to diagnostics and thus reduce healthcare costs by making high quality diagnostics more accessible to the people and places where they are most needed," Co-Diagnostics CEO Dwight Egan said in a statement.

Earlier this month, the company was fined $250,000 by the US Securities and Exchange Commission due to allegations of misleading press releases about COVID-19 tests and failing to disclose transactions involving executives' family members.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.